José María Alonso
José María Alonso publishes mostly in Hematology, Genetics and Molecular Biology, on topics such as Multiple Myeloma Research and Treatments, Myeloproliferative Neoplasms: Diagnosis and Treatment and Acute Myeloid Leukemia Research.
- World rank
- #2,497,586 of 7,710,434 ranked researchers
- Rank in Spain
- #54,740 of 204,306
- Works
- 48
- Citations
- 1.4k
- Citations per work
- 28.1
What does José María Alonso research?
José María Alonso's work is mostly in Medicine (55%), Biochemistry, Genetics and Molecular Biology (12%), Immunology and Microbiology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2755.3%
- Medicine2755.3%
- Everything else1224.3%
- Life Sciences1020.4%
- 1Hematology26% of their works
- 2Genetics16% of their works
- 3Molecular Biology12% of their works
- 4Oncology9% of their works
- 5Immunology8% of their works
- 6Pathology and Forensic Medicine4% of their works
Research topics
- Multiple Myeloma Research and Treatments
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Acute Myeloid Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Immunodeficiency and Autoimmune Disorders
- Lymphoma Diagnosis and Treatment
- Chronic Myeloid Leukemia Treatments
Which keywords describe José María Alonso's research?
The keywords of their largest research topics: Prognostic Factors, Diagnosis Criteria, International Myeloma Working Group, Rituximab, Acute Myeloid Leukemia, AML, JAK2 Mutation and Myelofibrosis.
- Imatinib
- Primary Immunodeficiency
- Genetic Mutations
- Transthyretin
- Genomic Aberrations
- Myelofibrosis
- Acute Myeloid Leukemia
- Rituximab
- Diagnosis Criteria
- Prognostic Factors
- International Myeloma Working Group
- AML
- JAK2 Mutation
- Chronic Lymphocytic Leukemia
- Cardiac Amyloidosis
- Classification
- Lymphoma
- BCR-ABL
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Prognostic Factors192 topics
- Diagnosis Criteria151 topic
- International Myeloma Working Group151 topic
- Rituximab142 topics
- AML101 topic
- Acute Myeloid Leukemia101 topic
- JAK2 Mutation101 topic
- Myelofibrosis101 topic
- Chronic Lymphocytic Leukemia91 topic
- Genomic Aberrations91 topic
- Cardiac Amyloidosis81 topic
- Transthyretin81 topic
- Classification51 topic
- Genetic Mutations51 topic
- Lymphoma51 topic
- Primary Immunodeficiency51 topic
- BCR-ABL41 topic
- Imatinib41 topic
Where does José María Alonso work?
José María Alonso's main affiliation in the publication record is Hospital General De Segovia, Spain.
How many publications and citations does José María Alonso have?
OpenAlex counts 48 works and 1,350 citations for José María Alonso, an h-index of 15, ranking #2,497,586 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about José María Alonso. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.